
    
      Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired clonal disorder of the hematopoietic
      stem cell characterized by intravascular hemolysis, hemoglobinuria, anemia, and thrombosis,
      Patients may be at high risk of thrombosis and may develop bone marrow failure or aplastic
      anemia, with low white blood cell and platelet counts,because the manifestation and
      pathologic processes are complicate,the treatment is very difficult,this study is designed to
      evaluate the safety and efficacy of Levamisole combined with cyclosporine A in patients with
      classic paroxysmal nocturnal hemoglobinuria
    
  